Joanne Wuensch
Stock Analyst at Citigroup
(4.61)
# 242
Out of 4,761 analysts
382
Total ratings
68.24%
Success rate
14.79%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $103 → $110 | $90.89 | +21.03% | 3 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $107 → $122 | $104.75 | +16.47% | 34 | Feb 6, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $640 → $711 | $596.90 | +19.12% | 16 | Jan 24, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $57 → $50 | $31.56 | +58.45% | 13 | Dec 11, 2024 | |
| SYK Stryker | Maintains: Buy | $411 → $450 | $384.22 | +17.12% | 12 | Dec 11, 2024 | |
| SGHT Sight Sciences | Maintains: Neutral | $5.8 → $4.6 | $2.75 | +67.58% | 9 | Dec 11, 2024 | |
| PEN Penumbra | Maintains: Neutral | $200 → $245 | $294.89 | -16.92% | 24 | Dec 11, 2024 | |
| NVRO Nevro | Maintains: Neutral | $6 → $5 | $5.73 | -12.74% | 19 | Dec 11, 2024 | |
| JNJ Johnson & Johnson | Maintains: Buy | $185 → $175 | $162.10 | +7.96% | 12 | Dec 11, 2024 | |
| ITGR Integer Holdings | Maintains: Neutral | $130 → $145 | $128.45 | +12.88% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $283 → $310 | $280.11 | +10.67% | 13 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $83 | $73.86 | +12.37% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $91 | $88.94 | +2.32% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $37 → $35 | $33.70 | +3.87% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $7.5 | $8.91 | -15.82% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $22 | $15.68 | +40.31% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $130.84 | +23.82% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $116 → $115 | $88.19 | +30.40% | 19 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $21.62 | +1.78% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $92 | $89.94 | +2.29% | 18 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $45 → $50 | $32.57 | +53.52% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $119.37 | -7.85% | 17 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $85 | $63.23 | +34.43% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $104.57 | +14.76% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $126 → $128 | $135.16 | -5.30% | 19 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $227.69 | +9.80% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $90.39 | -23.66% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $230.68 | -44.94% | 6 | Dec 10, 2018 |
GE HealthCare Technologies
Feb 13, 2025
Maintains: Buy
Price Target: $103 → $110
Current: $90.89
Upside: +21.03%
Boston Scientific
Feb 6, 2025
Maintains: Buy
Price Target: $107 → $122
Current: $104.75
Upside: +16.47%
Intuitive Surgical
Jan 24, 2025
Maintains: Buy
Price Target: $640 → $711
Current: $596.90
Upside: +19.12%
Tandem Diabetes Care
Dec 11, 2024
Maintains: Buy
Price Target: $57 → $50
Current: $31.56
Upside: +58.45%
Stryker
Dec 11, 2024
Maintains: Buy
Price Target: $411 → $450
Current: $384.22
Upside: +17.12%
Sight Sciences
Dec 11, 2024
Maintains: Neutral
Price Target: $5.8 → $4.6
Current: $2.75
Upside: +67.58%
Penumbra
Dec 11, 2024
Maintains: Neutral
Price Target: $200 → $245
Current: $294.89
Upside: -16.92%
Nevro
Dec 11, 2024
Maintains: Neutral
Price Target: $6 → $5
Current: $5.73
Upside: -12.74%
Johnson & Johnson
Dec 11, 2024
Maintains: Buy
Price Target: $185 → $175
Current: $162.10
Upside: +7.96%
Integer Holdings
Dec 11, 2024
Maintains: Neutral
Price Target: $130 → $145
Current: $128.45
Upside: +12.88%
Dec 11, 2024
Maintains: Buy
Price Target: $283 → $310
Current: $280.11
Upside: +10.67%
Dec 11, 2024
Maintains: Buy
Price Target: $81 → $83
Current: $73.86
Upside: +12.37%
Dec 11, 2024
Maintains: Buy
Price Target: $85 → $91
Current: $88.94
Upside: +2.32%
Dec 11, 2024
Maintains: Neutral
Price Target: $37 → $35
Current: $33.70
Upside: +3.87%
Dec 11, 2024
Downgrades: Neutral
Price Target: $17 → $7.5
Current: $8.91
Upside: -15.82%
Dec 11, 2024
Downgrades: Neutral
Price Target: $24 → $22
Current: $15.68
Upside: +40.31%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $130.84
Upside: +23.82%
Dec 6, 2024
Maintains: Buy
Price Target: $116 → $115
Current: $88.19
Upside: +30.40%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $21.62
Upside: +1.78%
Oct 1, 2024
Maintains: Neutral
Price Target: $85 → $92
Current: $89.94
Upside: +2.29%
Oct 1, 2024
Maintains: Neutral
Price Target: $45 → $50
Current: $32.57
Upside: +53.52%
Aug 22, 2024
Maintains: Buy
Price Target: $135 → $110
Current: $119.37
Upside: -7.85%
Aug 22, 2024
Maintains: Neutral
Price Target: $94 → $85
Current: $63.23
Upside: +34.43%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $104.57
Upside: +14.76%
Apr 3, 2024
Maintains: Buy
Price Target: $126 → $128
Current: $135.16
Upside: -5.30%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $227.69
Upside: +9.80%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $90.39
Upside: -23.66%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $230.68
Upside: -44.94%